Stephane Wong

1.2k total citations
15 papers, 802 citations indexed

About

Stephane Wong is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stephane Wong has authored 15 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Genetics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stephane Wong's work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (4 papers). Stephane Wong is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (4 papers). Stephane Wong collaborates with scholars based in United States, Australia and Argentina. Stephane Wong's co-authors include Owen N. Witte, Naomi Rosenberg, Jami McLaughlin, John Colicelli, Michael G. Kharas, Donghui Cheng, Jonathan A. Deane, Owen N. Witte, Kalindi Parmar and Ajay Dhaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Stephane Wong

15 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephane Wong United States	11	495	349	339	179	139	15	802
Annamaria Galietta Italy	6	441 0.9×	434 1.2×	309 0.9×	172 1.0×	143 1.0×	8	836
R B Arlinghaus United States	11	469 0.9×	204 0.6×	370 1.1×	185 1.0×	169 1.2×	17	725
Robert C. Quackenbush United States	7	501 1.0×	333 1.0×	311 0.9×	133 0.7×	174 1.3×	7	913
Vera Magistroni Italy	13	408 0.8×	336 1.0×	295 0.9×	173 1.0×	146 1.1×	23	783
G Q Daley United States	5	513 1.0×	194 0.6×	345 1.0×	166 0.9×	110 0.8×	5	641
Daniel W. Sherbenou United States	16	587 1.2×	349 1.0×	381 1.1×	199 1.1×	289 2.1×	40	911
Michael R. Burgess United States	16	586 1.2×	370 1.1×	272 0.8×	154 0.9×	336 2.4×	27	986
Thomas G.P. Bumm United States	13	771 1.6×	468 1.3×	819 2.4×	428 2.4×	336 2.4×	24	1.3k
JV Melo United Kingdom	11	849 1.7×	242 0.7×	637 1.9×	275 1.5×	135 1.0×	17	1.1k
AM Gewirtz United States	6	448 0.9×	279 0.8×	242 0.7×	89 0.5×	115 0.8×	7	664

Countries citing papers authored by Stephane Wong

Since Specialization

Citations

This map shows the geographic impact of Stephane Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephane Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephane Wong more than expected).

Fields of papers citing papers by Stephane Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephane Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephane Wong. The network helps show where Stephane Wong may publish in the future.

Co-authorship network of co-authors of Stephane Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Stephane Wong. A scholar is included among the top collaborators of Stephane Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephane Wong. Stephane Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mahon, François-Xavier, Carla Boquimpani, Dong‐Wook Kim, et al.. (2018). Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase. Annals of Internal Medicine. 168(7). 461–470. 95 indexed citations

Hughes, Timothy P., Carla Boquimpani, Dong‐Wook Kim, et al.. (2016). Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.. Journal of Clinical Oncology. 34(15_suppl). 7054–7054. 10 indexed citations

Huang, Alice H., et al.. (2015). International Scale (IS)-Standardized BCR-ABL1 Digital Polymerase Chain Reaction (dPCR) Assays Using ABL1, BCR, and GUS Control Genes for Measuring Deep Molecular Response (MR) in Chronic Myeloid Leukemia (CML). Blood. 126(23). 136–136. 2 indexed citations

Belloni, Benedetta, Chiara Lambertini, Paolo Nucíforo, et al.. (2012). Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system. Journal of Clinical Pathology. 66(2). 124–135. 42 indexed citations

Li, Jin, Weihua Liu, Zhenyu Yan, et al.. (2012). Next-Generation Sequencing of the BCR-ABL1 Kinase Domain and Neighboring Domains Associated with Therapy Resistance.. Blood. 120(21). 2549–2549. 1 indexed citations

O’Hare, Thomas, Matthew S. Zabriskie, Christopher A. Eide, et al.. (2011). The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Blood. 118(19). 5250–5254. 37 indexed citations

Kharas, Michael G., et al.. (2004). Phosphoinositide 3-kinase signaling is essential for ABL oncogene–mediated transformation of B-lineage cells. Blood. 103(11). 4268–4275. 73 indexed citations

Wong, Stephane & Owen N. Witte. (2004). The BCR-ABL Story: Bench to Bedside and Back. Annual Review of Immunology. 22(1). 247–306. 294 indexed citations

Wong, Stephane, Jami McLaughlin, Donghui Cheng, et al.. (2003). IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease. Proceedings of the National Academy of Sciences. 100(20). 11630–11635. 9 indexed citations

10.

Era, Takumi, Stephane Wong, & Owen N. Witte. (2003). Analysis of Bcr-Abl Function Using an In Vitro Embryonic Stem Cell Differentiation System. Humana Press eBooks. 185. 83–95. 11 indexed citations

11.

Wong, Stephane, Jami McLaughlin, Donghui Cheng, & Owen N. Witte. (2003). Cell context–specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors. Blood. 101(10). 4088–4097. 34 indexed citations

12.

Le, Lu Q., Janusz H. Kabarowski, Stephane Wong, et al.. (2002). Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene. Cancer Cell. 1(4). 381–391. 37 indexed citations

13.

Wong, Stephane & Owen N. Witte. (2001). Modeling Philadelphia chromosome positive leukemias. Oncogene. 20(40). 5644–5659. 53 indexed citations

14.

Lim, Young‐Mi, et al.. (2000). BCR/ABL inhibition by an escort/phosphatase fusion protein. Proceedings of the National Academy of Sciences. 97(22). 12233–12238. 37 indexed citations

15.

Afar, Daniel, Limin Han, Jami McLaughlin, et al.. (1997). Regulation of the Oncogenic Activity of BCR-ABL by a Tightly Bound Substrate Protein RIN1. Immunity. 6(6). 773–782. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact